Glycobiology Advance Access published online on May 3, 2006
Glycobiology, doi:10.1093/glycob/cwj119
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Structural Biology, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK
* To whom correspondence should be addressed. A mammalian GlcNAc transferase I (GnT I)-independent fucosylation pathway is revealed by the use of matrix-assisted laser desorption/ionization (MALDI) and negative ion nano-electrospray ionization mass spectrometry of N-linked glycans from natively folded recombinant glycoproteins, expressed in both human embryonic kidney (HEK) 293S or Chinese hamster ovary cells (CHO) Lec3.2.8.1 deficient in GnT I activity. The biosynthesis of core fucosylated Man5GlcNAc2 glycans was enhanced in CHO Lec3.2.8.1 cells by the
Received March 6, 2006
Revised April 20, 2006
Accepted April 20, 2006
Article
Inhibition of hybrid and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway
Max Crispin 1 *,
David J. Harvey 2,
Veronica T. Chang 3,
Chao Yu 3,
A. Radu Aricescu 4,
E. Yvonne Jones 4,
Simon J. Davis 3,
Raymond A. Dwek 2,
and
Pauline M. Rudd 2
2 Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK
3 Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK
4 Cancer Research UK Receptor Structure Research Group, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK
Max Crispin, E-mail: max{at}strubi.ox.ac.uk
![]()
Abstract
-glucosidase inhibitor, N-butyldeoxynojirimycin, leading to the increase in core fucosylated Man5GlcNAc2 glycans and the biosynthesis of a novel core fucosylated monoglucosylated oligomannose glycan, Glc1Man7GlcNAc2Fuc. Furthermore, no fucosylated Man9GlcNAc2 glycans were detected following inhibition of
-mannosidase I with kifunensine. Thus, core fucosylation is prevented by the presence of terminal
1-2 mannoses on the 6-antennae but not the 3-antennae of the trimannosyl core. Fucosylated Man5GlcNAc2 glycans were also detected on recombinant glycoprotein from HEK 293T cells following inhibition of Golgi
-mannosidase II with swainsonine. The paucity of fucosylated oligomannose glycans in wild-type mammalian cells is suggested to be due to kinetic properties of the pathway rather than the absence of the appropriate catalytic activity. The presence of the GnT I-independent fucosylation pathway is an important consideration when engineering mammalian glycosylation.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Crispin, V. T. Chang, D. J. Harvey, R. A. Dwek, E. J. Evans, D. I. Stuart, E. Y. Jones, J. M. Lord, R. A. Spooner, and S. J. Davis A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi {alpha}-Mannosidase II Locus J. Biol. Chem., August 7, 2009; 284(32): 21684 - 21695. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Bowden, M. Crispin, D. J. Harvey, A. R. Aricescu, J. M. Grimes, E. Y. Jones, and D. I. Stuart Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design J. Virol., December 1, 2008; 82(23): 11628 - 11636. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kanda, T. Yamada, K. Mori, A. Okazaki, M. Inoue, K. Kitajima-Miyama, R. Kuni-Kamochi, R. Nakano, K. Yano, S. Kakita, et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types Glycobiology, January 1, 2007; 17(1): 104 - 118. [Abstract] [Full Text] [PDF] |
||||


